Prevention and control of zoonoses at their source: from the Chinese perspective

Abstract

Zoonoses are a significant public health concern and cause considerable socioeconomic problems globally. The emergence of severe acute respiratory syndrome (SARS), highly pathogenic avian influenza (HPAI), and Ebola virus disease (EVD) has had a significant effect on the national economy and public health in China, and other countries. This review analyzed zoonotic disease issues faced by China, and the main factors contributing to the risk of zoonotic disease. The Chinese government has devised new strategies and has taken measures to deal with the challenges of these diseases, and the prevention and control of zoonoses at their source. A strategy that is suited to China’s national conditions, is proposed.

Keywords

zoonosis / prevention and control / joint prevention and control

References

[1] Jin N Y, Hu Z M, Feng S Z. New Zoonoses. Beijing, Science Press, 2007, 1167

[2] Liu Q, Cao L, Zhu X Q. Major emerging and re-emerging zoonoses in China: a matter of global health and socioeconomic development for 1.3 billion. International Journal of Infectious Diseases, 2014, 25C: 65–72

[3] Hui D S, Memish Z A, Zumla A. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome. Current Opinion in Pulmonary Medicine, 2014, 20(3): 233–241

[4] Chim S S, Lo Y M. Molecular epidemiology of the coronavirus associated with severe acute respiratory syndrome: a review of data from the Chinese University of Hong Kong. The Clinical Biochemist Reviews, 2004, 25(2): 143–147

[5] Freidl G S, Meijer A, de Bruin E, de Nardi M, Munoz O, Capua I, Breed A C, Harris K, Hill A, Kosmider R, Banks J, von Dobschuetz S, Stark K, Wieland B, Stevens K, van der Werf S, Enouf V, van der Meulen K, Van Reeth K, Dauphin G, KoopmansM, FLURISK Consortium. Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1). Eurosurveillance, 2014, 19(18): 20793

[6] Mertz D, Kim T H, Johnstone J, Lam P P, Science M, Kuster S P, Fadel S A, Tran D, Fernandez E, Bhatnagar N, Loeb M, Loeb M. Populations at risk for severe or complicated avian influenza H5N1: a systematic review and meta-analysis. PLoS ONE, 2014, 9(3): e89697

[7] WHO declares Ebola epidemic an international emergency. Available at Chinadaily website on August 15, 2014

[8] Morse S S, Mazet J A, Woolhouse M, Parrish C R, Carroll D, Karesh W B, Zambrana-Torrelio C, Lipkin W I, Daszak P. Prediction and prevention of the next pandemic zoonosis. The Lancet, 2012, 380(9857): 1956–1965

[9] Karesh W B, Dobson A, Lloyd-Smith J O, Lubroth J, Dixon M A, Bennett M, Aldrich S, Harrington T, Formenty P, Loh E H, Machalaba C C, Thomas M J, Heymann D L. Ecology of zoonoses: natural and unnatural histories. The Lancet, 2012, 380(9857): 1936–1945

[10] Liu Q, He B, Huang S Y, Wei F, Zhu X Q. Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. The Lancet Infectious Diseases, 2014, 14(8): 763–772

[11] Alexander D J. An overview of the epidemiology of avian influenza. Vaccine, 2007, 25(30): 5637–5644

[12] Vuitton D A, Zhou H, Bresson-Hadni S, Wang Q, Piarroux M, Raoul F, Giraudoux P. Epidemiology of alveolar echinococcosis with particular reference to China and Europe. Parasitology, 2003, 127(Suppl): S87–S107

[13] McMANUS D P. Prospects for development of a transmission blocking vaccine against. Schistosoma japonicum. Parasite Immunology, 2005, 27(7–8): 297–308

[14] Fooks A R, Banyard A C, Horton D L, Johnson N, McElhinney L M, Jackson A C. Current status of rabies and prospects for elimination. The Lancet, 2014first published online)

[15] Hemachudha T, Ugolini G, Wacharapluesadee S, Sungkarat W, Shuangshoti S, Laothamatas J. Human rabies: neuropathogenesis, diagnosis, and management. The Lancet Neurology, 2013, 12(5): 498–513

[16] Hu R, Tang Q, Tang J, Fooks A R. Rabies in China: an update. Vector Borne and Zoonotic Diseases, 2009, 9(1): 1–12

[17] Wu X, Hu R, Zhang Y, Dong G, Rupprecht C E. Reemerging rabies and lack of systemic surveillance in People’s Republic of China. Emerging Infectious Diseases, 2009, 15(8): 1159–1164

[18] Stenseth N C, Atshabar B B, Begon M, Belmain S R, Bertherat E, Carniel E, Gage K L, Leirs H, Rahalison L. Plague: past, present, and future. PLoS Medicine, 2008, 5(1): e3

[19] Wood J W, Ferrell R J, Dewitte-Aviña S N. The temporal dynamics of the fourteenth-century Black Death: new evidence from English ecclesiastical records. Human Biology, 2003, 75(4): 427–448

[20] Barde R. Plague in San Francisco: an essay review. Journal of the History of Medicine and Allied Sciences, 2004, 59(3): 463–470

[21] Faccini-Martínez A A, Sotomayor H A. Historical review of the plague in South America: a little-known disease in Colombia. Biomedica, 2013, 33(1): 8–27 (in Spanish)

[22] Tomori O. Yellow fever: the recurring plague. Critical Reviews in Clinical Laboratory Sciences, 2004, 41(4): 391–427

[23] Shi L, Ye R, Dong S, Guo Y, Yang G, Zhang R, Cui Z, Li W, Wang P. Genotyping and its epidemiological significance on Yunnan Yersinia pestis under Fse I enzyme digestion method. Zhonghua Liu Xing Bing Xue Za Zhi, 2014, 35(2): 182–185 (in Chinese)

[24] Li M, Dai E H, Dai R X, Zhou D S, Yang X Y, Cui B Z, Jin L X, Zhao H H, Li C X, Qi M Y, Ci Ren D Z, Dai X, Tang Y J, Yang R F. Study on the genotyping and microevolution of Yersinia pestis in the Qinghai-Tibet Plateau. Zhonghua Liu Xing Bing Xue Za Zhi, 2006, 27(5): 412–415 (in Chinese)

[25] Dawa W, Pan W J, Gu X Y, Zhang S Q, Dawa C, Yi X, Ciwang Z, Wang Y, Li S Y, Jiang R M. Clinical features, diagnosis and treatment of 5 cases of primary pneumonic plague in Tibet in 2010. Chinese Journal of Ttuberculosis and Respiratory Diseases, 2011, 34(6): 404–408 (in Chinese)

[26] A cases of plague patients in Sichuan. Available at Xinhua Net website on August 12, 2014

[27] Yang X Y, Li Y P, Mei Y W, Yu Y, Xiao J, Luo J, Yang Y, Wu S M. Time and spatial distribution of multidrug-resistant tuberculosis among Chinese people, 1981–2006: a systematic review. International Journal of Infectious Diseases, 2010, 14(10): e828–e837

[28] Marahatta S B. Multi-drug resistant tuberculosis burden and risk factors: an update. Kathmandu University Medical Journal, 2010, 8(29): 116–125

[29] Omotosho B A, Adebayo A M, Adeniyi B O, Ayodeji O O, Ilesanmi O S, Kareem A O, Akitikori O T, Erhabor G E. Tuberculosis treatment outcomes and interruption among patients assessing DOTS regimen in a tertiary hospital in semi-urban area of south-western Nigeria. Nigerian Journal of Medicine, 2014, 23(1): 51–56

[30] Chen J H, Wang H, Chen J X, Bergquist R, Tanner M, Utzinger J, Zhou X N. Frontiers of parasitology research in the People's Republic of China: infection, diagnosis, protection and surveillance. Parasites & vectors, 2012, 5: 221

[31] Xu J F, Lv S, Wang Q Y, Qian M B, Liu Q, Bergquist R, Zhou X N. Schistosomiasis japonica: modelling as a tool to explore transmission patterns. Acta Tropica, 2014 first published online)

[32] Wang Z H, Wang X M, Liu X Q. Echinococcosis in China, a review of the epidemiology of Echinococcus spp. EcoHealth, 2008, 5(2): 115–126

[33] Yang Y R, Craig P S, Sun T, Vuitton D A, Giraudoux P, Jones M K, Williams G M, McManus D P. Echinococcosis in Ningxia Hui Autonomous Region, northwest China. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2008, 102(4): 319–328

[34] Kaplan B S, Webby R J. The avian and mammalian host range of highly pathogenic avian H5N1 influenza. Virus Research, 2013, 178(1): 3–11

[35] Imai M, Herfst S, Sorrell E M, Schrauwen E J, Linster M, De Graaf M, Fouchier R A, Kawaoka Y. Transmission of influenza A/H5N1 viruses in mammals. Virus Research, 2013, 178(1): 15–20

[36] Hui D S, Chan P K. Severe acute respiratory syndrome and coronavirus. Infectious Disease Clinics of North America, 2010, 24(3): 619–638

[37] Cohen A L, Hellferscee O, Pretorius M, Treurnicht F, Walaza S, Madhi S, Groome M, Dawood H, Variava E, Kahn K, Wolter N, von Gottberg A, Tempia S, Venter M, Cohen C. Epidemiology of influenza virus types and subtypes in South Africa, 2009–2012. Emerging Infectious Diseases, 2014, 20(7): 1162–1169

[38] Yu H, Cowling B J, Feng L, Lau E H, Liao Q, Tsang T K, Peng Z, Wu P, Liu F, Fang V J, Zhang H, Li M, Zeng L, Xu Z, Li Z, Luo H, Li Q, Feng Z, Cao B, Yang W, Wu J T, Wang Y, Leung G M. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. The Lancet, 2013, 382(9887): 138–145

[39] Sekizawa J. Other aspects of BSE issues in East Asian countries. Risk Analysis, 2013, 33(11): 1952–1957

[40] Lee Y H, Kim M J, Tark D S, Sohn H J, Yun E I, Cho I S, Choi Y P, Kim C L, Lee J H, Kweon C H, Joo Y S, Chung G S, Lee J H. Bovine spongiform encephalopathy surveillance in the Republic of Korea. Revue Scientifique et Technique, 2012, 31(3): 861–870

[41] Kadohira M, Stevenson M A, Høgåsen H R, de Koeijer A. A quantitative risk assessment for bovine spongiform encephalopathy in Japan. Risk Analysis, 2012, 32(12): 2198–2208

[42] Chevalier V. Relevance of Rift Valley fever to public health in the European Union. Clinical Microbiology and Infection, 2013, 19(8): 705–708

[43] Artsob H, Gubler D J, Enria D A, Morales M A, Pupo M, Bunning M L, Dudley J P. West Nile virus in the new world: trends in the spread and proliferation of West Nile virus in the western hemisphere. Zoonoses and Public Health, 2009, 56(6–7): 357–369

[44] Feldmann H, Geisbert T W. Ebola haemorrhagic fever. The Lancet, 2011, 377(9768): 849–862

[45] MacNeil A, Rollin P E. Ebola and Marburg hemorrhagic fevers: neglected tropical diseases? PLoS Neglected Tropical Diseases, 2012, 6(6): e1546

[46] Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow M S, Keïta S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traoré A, Kolié M, Malano E R, Heleze E, Bocquin A, Mély S, Raoul H, Caro V, Cadar D, Gabriel M, Pahlmann M, Tappe D, Schmidt-Chanasit J, Impouma B, Diallo A K, Formenty P, Van Herp M, Günther S. Emergence of Zaire Ebola virus disease in Guinea – preliminary report. New England Journal of Medicine, 2014: 140416140039002

[47] 2014 West Africa Ebola virus outbreak. Available at Wikipedia website on August 13, 2014

[48] Kraaij-Dirkzwager M, Timen A, Dirksen K, Gelinck L, Leyten E, Groeneveld P, Jansen C, Jonges M, Raj S, Thurkow I, van Gageldonk-Lafeber R, van der Eijk A, Koopmans M. Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014. Eurosurveillance, 2014, 19(21): 20817

[49] Milne-Price S, Miazgowicz K L, Munster V J. The emergence of the Middle East Respiratory Syndrome coronavirus. Pathogens and Disease, 2014, 71(2): 119–134

[50] Cunha C B, Opal S M. Middle East Respiratory Syndrome (MERS): a new zoonotic viral pneumonia. Virulence, 2014, 5(6): 650–654

[51] Geng H, Tan W. A novel human coronavirus: Middle East Respiratory Syndrome human coronavirus. Science China Life Sciences, 2013, 56(8): 683–687

[52] Liu D Y. Manual of Security Sensitive Microbes and Toxins, CRC, 2014, 884

[53] Xinjiang acupuncture incident. Available at BaiduBaike website on August 10, 2014 (in Chinese)

[54] Asokan G V, Asokan V, Fedorowicz Z, Tharyan P. Use of a systems approach and evidence-based One Health for zoonoses research. Journal of Evidence-Based Medicine, 2011, 4(2): 62–65

[55] National medium- and long-term plan for animal epidemic prevention (2012–2020). Available at The Central People's Government of China website on August 10, 2014 (in Chinese)

[56] Xu W, Edwards M R, Borek D M, Feagins A R, Mittal A, Alinger J B, Berry K N, Yen B, Hamilton J, Brett T J, Pappu R V, Leung D W, Basler C F, Amarasinghe G K. Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1. Cell Host & Microbe, 2014, 16(2): 187–200

Acknowledgments

This work was supported by Consulting Research Project of the Chinese Academy of Engineering (NY3-2014), the National Key Technologies R&D Program (2013BAD12B04), Governmental Public Welfare Research Special Funds for Agriculture (201303042 and 201103032) and the National High Technology Research and Development Program of China (2012AA022006).

Compliance with ethics guidelinesƒSongtao Yang, Yuwei Gao, Jun Qian, Quan Liu, Xuexing Zheng, Hualei Wang, Zhiping Xia and Xianzhu Xia declare that they have no conflict of interest or financial conflicts to disclose.ƒThis article is a review and does not contain any studies with human or animal subjects performed by any of the authors.

RIGHTS & PERMISSIONS

Higher Education Press and Springer-Verlag Berlin Heidelberg